BOOK
Device Associated Infections, An Issue of Infectious Disease Clinics - E-Book
(2012)
Additional Information
Book Details
Abstract
Optimal management of device associated infections requires a collaborative approach among surgical and medical specialists—a need that is central to this issue of Infectious Diseases Clinics of North America. In addition to the epidemiology, management, and prevention of commonly encountered device associated infections, each review offers technical background on specific devices and related operative procedures. Areas of ongoing investigation are highlighted including innovative concepts for the prevention of biofilm formation and biofilm directed therapeutics. Emerging issues related to reuse of medical devices in resource limited settings are also considered.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Infectious Disease Clinics Of North America | i | ||
| Copyright Page | ii | ||
| Table of Contents | vii | ||
| Forthcoming Issues | xi | ||
| Contributors | iii | ||
| Preface | xiii | ||
| Chapter 1. New Developments in the Prevention of Intravascular Catheter Associated Infections | 1 | ||
| EPIDEMIOLOGY | 1 | ||
| PATHOGENESIS | 2 | ||
| NEW DEVELOPMENTS | 2 | ||
| PREVENTION: PERFORMANCE INITIATIVES | 3 | ||
| PREVENTION: TECHNOLOGIC INNOVATIONS | 5 | ||
| SUMMARY | 7 | ||
| REFERENCES | 8 | ||
| Chapter 2. Urinary Catheter-Associated Infections | 13 | ||
| DEFINITIONS | 13 | ||
| PATHOGENESIS | 14 | ||
| EPIDEMIOLOGY | 15 | ||
| DIAGNOSIS | 17 | ||
| TREATMENT | 19 | ||
| PREVENTION | 20 | ||
| SUMMARY | 24 | ||
| REFERENCES | 25 | ||
| Chapter 3. Management and Prevention of Prosthetic Joint Infection | 29 | ||
| PATHOGENESIS AND RISK FACTORS | 29 | ||
| MICROBIOLOGY | 30 | ||
| CLINICAL PRESENTATION AND DIAGNOSIS | 30 | ||
| TREATMENT | 32 | ||
| PREVENTION | 34 | ||
| SUMMARY | 35 | ||
| REFERENCES | 35 | ||
| Chapter 4. Vascular Graft Infections | 41 | ||
| PATHOGENESIS | 41 | ||
| RISK FACTORS AND MICROBIOLOGY | 42 | ||
| CLINICAL MANIFESTATIONS | 43 | ||
| DIAGNOSIS | 44 | ||
| CLINICAL MANAGEMENT | 45 | ||
| PREVENTION | 52 | ||
| SUMMARY | 53 | ||
| REFERENCES | 53 | ||
| Chapter 5. Cardiovascular Implantable Electronic Device Associated Infections | 57 | ||
| EPIDEMIOLOGY AND RISK FACTORS | 58 | ||
| MICROBIOLOGY | 59 | ||
| DIAGNOSIS | 60 | ||
| MANAGEMENT OF CARDIAC DEVICE INFECTIONS | 63 | ||
| PREVENTION | 69 | ||
| SUMMARY | 70 | ||
| REFERENCES | 70 | ||
| Chapter 6. Left Ventricular Assist Device–Associated Infections | 77 | ||
| OVERVIEW OF LVADs | 78 | ||
| OUTCOMES OF MECHANICAL SUPPORT | 79 | ||
| LVAD INFECTIONS | 80 | ||
| SUMMARY | 84 | ||
| REFERENCES | 84 | ||
| Chapter 7. Central Nervous System Device Infections | 89 | ||
| CSF DIVERSION WITH SHUNTS: SHUNT INFECTIONS | 99 | ||
| DEEP BRAIN STIMULATOR INFECTIONS | 100 | ||
| SUMMARY | 104 | ||
| REFERENCES | 104 | ||
| Chapter 8. Breast Implant Infections | 111 | ||
| EPIDEMIOLOGY AND COSTS | 112 | ||
| RISK FACTORS | 112 | ||
| PATHOGENESIS AND MICROBIOLOGY | 114 | ||
| DIAGNOSIS | 117 | ||
| MANAGEMENT | 118 | ||
| PREVENTION | 119 | ||
| SUMMARY | 121 | ||
| REFERENCES | 121 | ||
| Chapter 9. Infectious Complications of Dialysis Access Devices | 127 | ||
| HEMODIALYSIS ACCESS | 128 | ||
| PERITONEAL DIALYSIS ACCESS | 134 | ||
| SUMMARY | 136 | ||
| ACKNOWLEDGMENTS | 136 | ||
| REFERENCES | 136 | ||
| Chapter 10. Medical Device – Associated Infectionsin the Long -Term Care Setting | 143 | ||
| USE OF INVASIVE MEDICAL DEVICES IN LTCFS | 144 | ||
| INFECTION OF INDWELLING URINARY CATHETERS | 144 | ||
| INFECTION OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBES | 148 | ||
| INFECTION OF INTRAVASCULAR DEVICES | 152 | ||
| INFECTION OF TRACHEOSTOMY DEVICES | 155 | ||
| SUMMARY | 158 | ||
| REFERENCES | 158 | ||
| Chapter 11. Reuse of Medical Devices: Implications for Infection Control | 165 | ||
| REPROCESSING AND STERILIZATION OF MEDICAL DEVICES | 166 | ||
| GUIDANCE FOR REUSE OF SINGLE-USE DEVICES | 166 | ||
| INFECTION CONTROL ISSUES RELATED TO THE REUSE OF MEDICAL DEVICES | 167 | ||
| ECONOMIC AND ETHICAL CONSIDERATIONS FOR REUSE OF SINGLE-USE DEVICES | 169 | ||
| REUSE OF COMPLEX SINGLE-USE MEDICAL DEVICES IN RESOURCE-LIMITED SETTINGS | 170 | ||
| SUMMARY | 170 | ||
| REFERENCES | 170 | ||
| Chapter 12. Novel Approaches to the Diagnosis, Prevention, and Treatment of Medical Device-Associated Infections | 173 | ||
| PREVENTION OF BIOFILM FORMATION | 174 | ||
| ENHANCEMENT OF ANTIMICROBIAL ACTIVITY AGAINST BIOFILM BACTERIA | 175 | ||
| CATHETER-ASSOCIATED URINARY TRACT INFECTION | 175 | ||
| CATHETER-ASSOCIATED BLOODSTREAM INFECTION | 177 | ||
| INFECTION ASSOCIATED WITH ORTHOPEDIC IMPLANTS | 179 | ||
| INFECTION OF CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES | 181 | ||
| SUMMARY | 181 | ||
| REFERENCES | 182 | ||
| Index | 187 |